Discovering a Therapeutic Approach for IPF Utilizing Inhaled Antisense Oligonucleotides

Time: 4:00 pm
day: Day One

Details:

  • Investigating antisense as therapy for pulmonary fibrosis
  • Optimizing antisense therapeutic design for targeting various cell types in lung
  • Evaluating antisense inhibitors in mouse models of IPF

Speakers: